Agreement to file a friendly takeover bid initiated by OncoDNA on IntegraGen to acquire all outstanding shares at a price of 2.20€ per share

Gosselies, Belgium – Évry, France July 9th, 2020
 
This transaction would bring together OncoDNA’s expertise in oncology precision medicine and IntegraGen’s know-how in DNA sequencing services and bioinformatics analyses. The combination of both companies would enable to offer a complete solution that combines oncology laboratory testing and software solutions which will benefit the treatment of patients with advanced cancer.

Download PDF

You may also be interested in these resources

Scientific Application Note

What’s on the horizon for immunotherapy?

There’s an old adage in medicine that no sick patient should die without a trial of steroids. We are, perhaps, moving towards a similar paradigm in oncology, where everyone with advanced cancer receives a trial...

Read more →
logo primaire 2019 06 (white)

OncoDNA is a theranostic and genomic company with renown expertise in precision oncology and genetic diseases.

Company

OncoDNA S.A. (headquarters)
Rue Louis Breguet 1
BE-6041 Gosselies

+32 (0) 71 18 35 00

Links

Support

©OncoDNA 2024. All rights reserved. VAT:BE0501631837
Made by Créatonit   Sitemap
Share This